Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Forward ScienceROCO:7530 +6.27%37 3-Year ROIIC % is 24.92 as of Dec. 2025, which is 606% above its 10-year median of 3.53. GuruFocus rates ROCO:7530 with a GF Score™ of 37/100 and a GF Value™ of NT$14.04 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 2,931 Industrial Products companies, Forward Science ranks better than 77.65% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Forward Science's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 24.92%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Forward Science's 3-Year ROIIC % or its related term are showing as below:
ROCO:7530's 3-Year ROIIC % is ranked better than 77.65% of 2931
companies
in the Industrial Products industry
Industry Median: 3.45
vs ROCO:7530: 24.92
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Forward Science 3-Year ROIIC % Related Terms
Forward Science 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Forward Science's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7530 vs GEV, ETN, PH: 3-Year ROIIC % Comparison
For the Specialty Industrial Machinery subindustry, Forward Science's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Forward Science 3-Year ROIIC % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Forward Science's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Forward Science's 3-Year ROIIC % falls into.
Forward Science's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -74.395 (Dec. 2025) - -59.559 (Dec. 2022) )
/
( 588.882 (Dec. 2025) - 648.415 (Dec. 2022) )
=
-14.836
/
-59.533
=
24.92%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Forward Science (ROCO:7530) has a 3-Year ROIIC % of 24.92 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Forward Science and its competitors. This is 606% above median its historical median of 3.53. According to the industry distribution chart, Forward Science ranks #655 out of 2931 companies in the Industrial Products industry, placing it in the top 22.3%.
Is Forward Science's 3-Year ROIIC % too high?
Forward Science's current 3-Year ROIIC % of 24.92 is 606% above median its 10-year median of 3.53. The Industrial Products industry median 3-Year ROIIC % is 3.45. Forward Science's value of 24.92 is 622.3% above this industry median. Based on the distribution chart, Forward Science ranks #655 out of 2931 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Forward Science has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Forward Science's 3-Year ROIIC % compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Forward Science ranks #655 out of 2931 companies for 3-Year ROIIC %. This places Forward Science in the top 22% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.45. Forward Science's value of 24.92 is 622.3% above this benchmark. While the company's 10-year median is 3.53 vs. the industry median of 3.45, Forward Science has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for an Industrial Products company?
The median 3-Year ROIIC % among Industrial Products companies is 3.45, based on 2,931 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Forward Science's current 3-Year ROIIC % of 24.92 is 622.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Forward Science and its competitors. For the Industrial Products industry, the median 3-Year ROIIC % is 3.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Forward Science's current 3-Year ROIIC % is 24.92, which is 606% above median its own 10-year median of 3.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forward Science stock overvalued right now?
Based on GuruFocus' analysis, Forward Science (ROCO:7530) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$14.04, compared to a current price of NT$34.75 — trading 147.5% above its estimated fair value. The current 3-Year ROIIC % is 24.92, which is 606% above median its 10-year median of 3.53 and 622.3% above the Industrial Products industry median of 3.45. Forward Science's overall GF Score™ is 37/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Forward Science (ROCO:7530), the current 3-Year ROIIC % is 24.92 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Forward Science (ROCO:7530) Overvalued in 2026?
Based on GuruFocus' analysis, Forward Science stock appears to be overvalued.
The current stock price of NT$34.75 is trading 147.5% above its estimated GF Value™ of NT$14.04.
GuruFocus considers Forward Science to be Significantly Overvalued.
Key valuation signals for ROCO:7530:
3-Year ROIIC %: 24.92 (606% above median its 10-year median of 3.53)
GF Value™: NT$14.04 vs. price of NT$34.75 (147.5% above fair value)
Industry Position: 622.3% above the Industrial Products median (#655 of 2931)
No single metric tells the full story. See the ROCO:7530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Forward Science Corp is engaged in the manufacturing and maintenance of vacuum pumps. It is also involved in precision parts manufacturing that includes Stainless Processing, Aluminum Processing, Casting Processing, and Metal Finishing among others. Geographically, the company generates the majority of its revenue from Taiwan.
37GF Score
Get the complete analysis for ROCO:7530
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7530 has been successfully added to your 
